Finoriq research workspace
Addex Therapeutics Ltd. (ADXN) Historical Metrics
Review reported fundamentals, derived ratios, valuation context, and historical charts for Addex Therapeutics Ltd. (ADXN).
Company Snapshot
- Company
- Addex Therapeutics Ltd. (ADXN)
- Ticker
- ADXN
- Market Cap
- $7.1M
- Latest Price
- $5.60
- Industry
- Biotech & Pharma
Addex Therapeutics Ltd. (ADXN) Current Valuation Metrics
Static valuation preview for Addex Therapeutics Ltd. (ADXN). Market data retrieved 2026-07-09. Filing currency CHF.
| Metric | Value | Source |
|---|---|---|
| P/EMarket cap divided by latest TTM net income. | 1.09x | Net Income | TTM FY 2024 |
| P/SMarket cap divided by latest TTM revenue. | 19.1x | Revenue | TTM FY 2024 |
| Earnings YieldLatest TTM net income divided by market cap. | 91.6% | Net Income | TTM FY 2024 |
| Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap. | -69.8% | Operating Cash Flow | TTM FY 2024 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.